nā holomua i ka mālama ʻana i ka maʻi maʻi maʻi

Ua ʻike ka mālama ʻana i ka maʻi maʻi ʻaʻai i ka holomua kupaianaha i nā makahiki i hala iho nei. ʻIke kēia ʻatikala i nā mea hou loa nā holomua i ka mālama ʻana i ka maʻi maʻi maʻi, e uhi ana i nā lāʻau lapaʻau hou e like me ka lāʻau lapaʻau i hoʻopaʻa ʻia, immunotherapy, a me nā ʻano hana ʻokiʻoki liʻiliʻi. Hoʻopili mākou i nā kikoʻī o kēia mau lapaʻau, nā pōmaikaʻi, a me nā hopena ʻaoʻao, e hāʻawi ana i kahi ʻike piha no ka poʻe e ʻimi nei i ka ʻike e pili ana i nā koho ʻokiʻoki i loaʻa no ka mālama ʻana i ka maʻi kanesa o ka maʻi maʻi. ʻO ka NSCLC ka ʻano maʻamau, e helu ana ma kahi o 80-85% o nā maʻi maʻi kanesa āpau. He mea koʻikoʻi ka pae o ka maʻi ʻaʻai māmā i ka hoʻoholo ʻana i ka hoʻolālā lapaʻau kūpono. Hoʻokumu ʻia ka staging ma ka nui a me ka wahi o ka maʻi ʻaʻai, inā ua pālahalaha ʻia i nā ʻōpū lymph, a inā ua metastasized i nā kino mamao. Mea nui nā holomua i ka mālama ʻana i ka maʻi maʻi maʻi ua hana ʻia i loko o nā ʻano hana ʻokiʻoki, e hāʻawi ana i nā mea maʻi i nā koho invasive liʻiliʻi a me nā hopena i hoʻomaikaʻi ʻia. Minimally Invasive Techniques: VATS a me Robotic SurgeryVideo-Assisted Thoracoscopic Surgery (VATS) a me ka hōʻoki robotic he minimly invasive approaches e hoʻohana ana i nā ʻoki liʻiliʻi a me nā mea hana kūikawā. Hāʻawi kēia mau ʻenehana i nā mea maikaʻi ma mua o ke kaʻina wehe kuʻuna, ʻo ia hoʻi: Hoʻemi ʻia ka ʻeha a me ka ʻulaʻula Noho ʻo ka haukapila pōkole ʻO nā manawa hoʻōla wikiwiki ʻO kēia mau ala e alakaʻi pinepine ai i ka emi ʻana o ke koko a me ka emi ʻana o ka pilikia o nā pilikia, e lilo lākou i koho kaulana no nā maʻi kūpono. No ka ʻike hou aku e pili ana i nā koho ʻokiʻoki, e kūkākūkā me nā kauka lapaʻau ma nā keʻena like Shandong Baofa Cancer Research Institute, ka mea loea i kēia mau ʻenehana holomua.SBRT: Stereotactic Body Radiation TherapyStereotactic Body Radiation Therapy (SBRT) he ʻano kikoʻī loa o ka lāʻau lapaʻau i hoʻohana ʻia no ka mālama ʻana i nā maʻi ʻōpū liʻiliʻi o ka wā mua, ʻoi aku i nā maʻi i kūpono ʻole i nā moho no ke ʻoki. Hāʻawi ʻo SBRT i nā kiʻekiʻe kiʻekiʻe o ka radiation i ka ʻōpū ʻoiai e hōʻemi ana i ka ʻike ʻana i ka ʻiʻo olakino e pili ana. Ke hilinaʻi nei kēia ala i ka ʻike ʻana i nā hoʻololi genetic kikoʻī a i ʻole nā ​​protein e hoʻoulu ai i ka ulu ʻana o ka maʻi maʻi. Hoʻopaʻa kēia mau lāʻau lapaʻau i nā ala hōʻailona e hoʻoikaika i ka ulu ʻana a me ke ola ʻana o ka maʻi maʻi. Hoʻopaʻa kēia mau lāʻau i ka hana o ka protein ALK, ka mea e hoʻoulu ai i ka ulu ʻana o ka maʻi kanesa. Eia kekahi mau laʻana: Osimertinib (Tagrisso): He mea hoʻopale EGFR no NSCLC me nā hoʻololi EGFR kikoʻī. Crizotinib (Xalkori): ʻO kahi mea pale ALK no NSCLC me ka hoʻonohonoho hou ʻana o ka gene ALK. Bevacizumab (Avastin): He mea pale VEGF e kuhikuhi ana i ka ulu ʻana o ka moku koko i nā maʻi ʻaʻai. ʻO ka Immunotherapy: Hoʻohana ʻana i ka Pūnaehana Immune ʻO ka Immunotherapy kahi ʻano o ka mālama ʻana i ka maʻi maʻi e kōkua i ke kino o ke kino e hakakā i ka maʻi kanesa. Hoʻohana kēia ʻano i nā lāʻau lapaʻau e ālai ai i nā wahi hōʻoia, e ʻae ana i ka ʻōnaehana pale e ʻike a hoʻouka i nā pūnaewele maʻi maʻi me ka maikaʻi loa. Hoʻopaʻa kēia mau lāʻau i nā protein e pale ai i ka ʻōnaehana pale mai ka hoʻouka ʻana i nā maʻi maʻi maʻi. Eia kekahi laʻana: Pembrolizumab (Keytruda): He mea hoʻopale PD-1 Nivolumab (Opdivo): He mea hoʻopale PD-1 Atezolizumab (Tecentriq): A PD-L1 inhibitorCAR T-Cell Therapy ʻOiai ʻaʻole ia he lapaʻau maʻamau no ka hapa nui o nā maʻi maʻi ʻaʻai māmā, hōʻike ʻo CAR T-cell therapy i ka ʻōlelo hoʻohiki i kekahi mau hihia a ke noiʻi ikaika ʻia nei i nā hoʻokolohua lapaʻau. Hoʻopili kēia lāʻau lapaʻau i ka hoʻololi ʻana i nā keena T ponoʻī o ka mea maʻi no ka ʻike a hoʻouka ʻana i nā maʻi maʻi maʻi. ʻOiai ua puka mai nā lāʻau lapaʻau hou, hoʻohana pinepine ʻia ka chemotherapy i hui pū ʻia me ka therapy targeted a i ʻole immunotherapy no ka hoʻomaikaʻi ʻana i nā hopena. ʻO ke komo ʻana i kahi hoʻokolohua lapaʻau hiki ke hāʻawi i ke ala i nā lāʻau lapaʻau ʻokiʻoki ʻaʻole i loaʻa ākea. Pono nā poʻe maʻi makemake i nā hoʻokolohua lapaʻau e kūkākūkā i kēia koho me kā lākou oncologist. Side Effect Management: Improving Quality of LifeManaging side effects is an integral part of lung cancer treatment. ʻO ka nui o nā lāʻau lapaʻau hou, e like me ka hoʻomaʻamaʻa ʻana a me ka immunotherapy, loaʻa nā ʻaoʻao hopena ʻaoʻao like ʻole i hoʻohālikelike ʻia me ka chemotherapy kuʻuna. Hiki ke hoʻomaikaʻi maikaʻi ka hoʻokele hopena ʻaoʻao i ka maikaʻi o ke ola o ka poʻe maʻi i ka wā lapaʻau. Ke hoʻomau nei ka noiʻi ʻana i ka hoʻomohala ʻana i nā lāʻau lapaʻau hou, immunotherapies, a me nā mea hana diagnostic. ʻO kēia mau mea nā holomua i ka mālama ʻana i ka maʻi maʻi maʻi paʻa i ka ʻōlelo hoʻohiki no ka hoʻomaikaʻi ʻana i nā hopena a me ka hoʻonui ʻana i ke ola o nā poʻe maʻi me ka maʻi kanesa maʻi. He mea koʻikoʻi ke kūkākūkā me kāu kauka e hoʻoholo i ka hoʻolālā lapaʻau maikaʻi loa no kāu kūlana kikoʻī. Lapaʻau ʻO ka hoʻohana maʻamau Nā pōmaikaʻi hiki ke loaʻa nā hopena ʻaoʻao hiki ke ʻoki ʻia NSCLC i ka wā mua ʻO ka hiki ke ho'ōla i ka wā mua ʻO ka ʻeha, ka maʻi, ke koko, ka pilikia o ka māmā. ʻōnaehana no ka hakakā ʻana i ka maʻi kanesa, nā pane paʻa i kekahi mau maʻi ʻO nā hopena autoimmune, luhi, ʻūlū, ʻaʻa o nā kino Chemotherapy ʻO nā ʻano like ʻole o ka maʻi maʻi ʻaʻai Hiki ke hōʻemi i nā ʻōpū a hoʻolōʻihi i ke ola Nausea, luaʻi, lauoho lauoho, luhi, helu haʻahaʻa koko. Hōʻole: Hāʻawi kēia ʻatikala i ka ʻike maʻamau a ʻaʻole pono e manaʻo ʻia he ʻōlelo aʻoaʻo olakino. E kūkākūkā me kekahi loea mālama ola kino no ke alakaʻi pilikino e pili ana i ka ʻike a me ka mālama ʻana i ka maʻi kanesa.